{"id":"https://openalex.org/W7225344170","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0056","title":"56 Myeloid architecture and CD8 + T-cell-to-tumor distance dictate immunotherapy outcomes in osteosarcoma","display_name":"56 Myeloid architecture and CD8 + T-cell-to-tumor distance dictate immunotherapy outcomes in osteosarcoma","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225344170","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0056"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0056","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0056","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0056","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A62.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A62.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160787443","display_name":"Alexander Borysov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Borysov","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119715951","display_name":"Puttawat Suphaprueksapong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Puttawat Suphaprueksapong","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102000405","display_name":"Chong Zhao","orcid":"https://orcid.org/0000-0003-2932-153X","observed_orcids":["https://orcid.org/0000-0003-2932-153X"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chong Zhao","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069489825","display_name":"Frances L. Weidert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frances Weidert","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052899691","display_name":"Darrice S. Montgomery","orcid":"https://orcid.org/0000-0003-2481-8432","observed_orcids":["https://orcid.org/0000-0003-2481-8432"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darrice Montgomery","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010996192","display_name":"H\u00e9ctor M\u00e9ndez-G\u00f3mez","orcid":"https://orcid.org/0000-0002-7493-5365","observed_orcids":["https://orcid.org/0000-0002-7493-5365"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hector Mendez-Gomez","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084358385","display_name":"Andria L. Doty","orcid":"https://orcid.org/0000-0001-6489-4013","observed_orcids":["https://orcid.org/0000-0001-6489-4013"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andria Doty","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030564714","display_name":"Elias Joseph Sayour","orcid":"https://orcid.org/0000-0002-5309-3197","observed_orcids":["https://orcid.org/0000-0002-5309-3197"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elias Sayour","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I33213144"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A62","last_page":"A62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-osteosarcoma","display_name":"metastatic osteosarcoma","score":0.9359999895095825},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8759999871253967},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/adaptive-resistance","display_name":"adaptive resistance","score":0.6340000033378601},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8870000243186951},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.843999981880188},{"id":"https://openalex.org/keywords/pmn-mdscs","display_name":"polymorphonuclear myeloid-derived suppressor cells","score":0.9440000057220459},{"id":"https://openalex.org/keywords/t-cell-exclusion","display_name":"T-cell exclusion","score":0.5830000042915344},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7200000286102295},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7204999923706055},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5638999938964844},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5569000244140625},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5482000112533569},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5327000021934509},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4896000027656555},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4812000095844269},{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.4357999861240387},{"id":"https://openalex.org/C77255625","wikidata":"https://www.wikidata.org/wiki/Q402093","display_name":"Reprogramming","level":3,"score":0.42969998717308044},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4187000095844269},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.391400009393692},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3727000057697296},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.34860000014305115},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.31380000710487366},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.29820001125335693},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.2964000105857849},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28220000863075256},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.28060001134872437},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2791999876499176},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.26420000195503235}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0056","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0056","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0056","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A62.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0056","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0056","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0056","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A62.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225344170.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7225316341","https://openalex.org/W3099199022","https://openalex.org/W2955008148","https://openalex.org/W4415900372","https://openalex.org/W3160748480","https://openalex.org/W4384119880","https://openalex.org/W4409147818","https://openalex.org/W4411580641","https://openalex.org/W7223011525","https://openalex.org/W4402924989"],"abstract_inverted_index":{"Background":[0],"Metastatic":[1],"osteosarcoma":[2],"(OSA)":[3],"is":[4,59,310],"largely":[5],"refractory":[6],"to":[7,12,53,61,193,211,224,236,285,306,312],"immune":[8],"checkpoint":[9],"blockade":[10,275],"due":[11],"an":[13,137],"immunosuppressive,":[14],"myeloid-dominated":[15],"tumor":[16,24,54,200,221],"microenvironment":[17],"(TME).":[18],"Reprogramming":[19],"the":[20,45,102,197,288,307],"TME":[21,41,139,228,315],"with":[22,83,170,178,217],"total":[23],"(tt)":[25],"mRNA-lipid":[26],"particle":[27],"aggregate":[28],"(mRNA-LPA)":[29],"vaccines":[30],"drives":[31,241],"systemic":[32],"immunity,":[33],"but":[34],"adaptive":[35,271],"resistance":[36,63],"limits":[37],"monotherapy":[38,135,240],"efficacy.":[39],"Understanding":[40],"spatial":[42,116,214,229,278,299],"topology,":[43],"specifically":[44],"distribution":[46],"of":[47,133,199,270],"CD8":[48,152,281],"+":[49,153,282],"T":[50,154,206,243,283],"cells":[51,155,201,207,244,284],"relative":[52,292],"and":[55,65,120,127,146,167,196],"suppressive":[56,249],"myeloid":[57,165,250],"populations,":[58],"critical":[60],"deciphering":[62],"mechanisms":[64],"optimizing":[66],"combinations.Methods":[67],"A":[68],"murine":[69],"OSA":[70,227],"lung":[71,95],"metastasis":[72],"model":[73],"(K7M2,":[74],"1.25":[75],"\u00d7":[76],"10":[77],"6":[78],"cells/mouse":[79],"i.v.)":[80],"was":[81],"treated":[82],"anti-PD-1":[84,179],"monotherapy,":[85,87],"tt-mRNA-LPA":[86],"combination":[88],"therapy,":[89],"or":[90],"left":[91],"untreated.":[92],"FFPE":[93],"whole":[94],"sections":[96],"(4":[97],"\u00b5m)":[98],"were":[99,123,161,253],"stained":[100],"using":[101],"Akoya":[103],"PhenoCycler":[104],"panel":[105],"(i.e.,":[106],"CD3,":[107],"CD8,":[108],"FoxP3,":[109],"F4/80,":[110],"Arg1,":[111],"CD206,":[112],"S100A9,":[113],"Vimentin).":[114],"High-dimensional":[115],"analysis,":[117],"neighborhood":[118],"mapping,":[119],"distance":[121,187,293],"thresholding":[122],"performed":[124],"via":[125],"QuPath":[126],"Python-based":[128],"Leiden":[129],"clustering.Results":[130],"Spatial":[131],"profiling":[132],"mRNA-LPA":[134,177,239],"revealed":[136],"immunosuppressive":[138],"dominated":[140],"by":[141,204,248],"M2-like":[142],"tumor-associated":[143],"macrophages":[144],"(TAMs)":[145],"PMN-MDSCs.":[147],"Tumor":[148],"nests":[149],"geographically":[150,246],"excluded":[151,247],"(exclusion":[156],"z":[157],"=":[158,174],"+51),":[159],"which":[160,252],"instead":[162],"sequestered":[163],"within":[164],"niches":[166],"co-localized":[168],"preferentially":[169],"M2":[171],"TAMs":[172],"(z":[173],"+21).":[175],"Combining":[176],"partially":[180],"broke":[181],"this":[182,277],"exclusion.":[183],"The":[184,226,290],"median":[185],"CD8-to-tumor":[186,291],"decreased":[188],"dramatically":[189],"from":[190,209,258],"50":[191],"\u00b5m":[192],"19":[194],"\u00b5m,":[195],"proportion":[198],"directly":[202],"contacted":[203],"CD8+":[205],"increased":[208],"14%":[210],"35%.":[212],"This":[213],"engagement":[215],"correlated":[216],"a":[218,233,268,296],"reduced":[219],"overall":[220],"fraction":[222],"(22%":[223],"15%).Conclusions":[225],"architecture":[230],"acts":[231],"as":[232,295],"primary":[234],"barrier":[235],"immunotherapy.":[237],"While":[238],"infiltration,":[242],"remain":[245],"networks,":[251],"observed":[254],"across":[255],"osteosarcoma-bearing":[256],"lungs":[257],"multiple":[259],"treatment":[260],"groups,":[261],"suggesting":[262,301],"that":[263,302],"their":[264],"persistence":[265],"may":[266],"represent":[267],"mechanism":[269],"resistance.":[272,316],"Adding":[273],"PD-1":[274],"bridges":[276],"gap,":[279],"enabling":[280],"physically":[286],"engage":[287],"tumor.":[289],"serves":[294],"crucial":[297],"predictive":[298],"biomarker,":[300],"adding":[303],"myeloid-targeting":[304],"therapeutics":[305],"mRNA-LPA/anti-PD-1":[308],"regimen":[309],"necessary":[311],"fully":[313],"overcome":[314]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-06T00:00:00"}